Jan 2, 2019 · 22m · a16z
a16z Podcast | Nootropics and the Best Version of Your Brain, Yourself
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of the a16z podcast, host Kyle Russell and guests explore nootropics and biohacking with Nootrobox co-founders Geoffrey Wu and Michael Brandt. The discussion covers cognitive enhancement mechanisms, open-source formulations, quantified self data integration, and the potential societal impact of democratized smart drugs.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The host holds 2.9% of the talking time here. How this is scored →
speaking balance: gold is the host, purple is the guest (3 minute bins)
Michael pushes back against Kyle's concern about cognitive inequality by bringing up $10 Android phones to argue that tech trends quickly democratize.
Hardest push from the host ▶ 5:12 Saku Challenges Efficacy vs Medical AdoptionSaku directly challenges the guest's claims of efficacy by questioning why doctors do not prescribe these supplements if they are truly effective.
Biggest teaching moment ▶ 5:18 Jeff Explains Pharmaceutical Patent EconomicsJeff educates the hosts on how 20-year patent monopolies drive pharma R&D spending, explaining why non-patentable generic compounds lack clinical funding despite potential benefits.
The host holds their own ▶ 21:43 Kyle Demonstrates Expertise on Metcalfe's LawKyle demonstrates deep domain knowledge by immediately defining Metcalfe's Law and illustrating it with the historical hardware deployment of Ethernet cards.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The host as informed peer | Guest teaching | Guest disagreement | The host pushing back | Why |
|---|---|---|---|---|---|---|
| Defining Nootropics and Mechanisms Beyond Coffee | 2 | 5 | 1 | 0 | The hosts ask introductory questions about coffee alternatives, allowing the guests to outline three specific neurochemical and vascular pathways of cognitive enhancers. | |
| Scientific Validation, Generic Compounds, and FDA Dynamics | 4 | 6 | 1 | 4 | Saku raises a critical challenge asking why doctors do not prescribe these supplements if they work, prompting Jeff to explain pharmaceutical patent economics and generic compound dynamics. | |
| Addressing Supplement Industry Transparency and Open Source Formulas | 6 | 4 | 1 | 3 | Saku demonstrates deep familiarity with the topic by pointing out the supplement industry's opacity around proprietary blends and detailing r/nootropics community dynamics. | |
| Transitioning to Consumer Products and Future Form Factors | 4 | 3 | 0 | 1 | Kyle uses an insightful Apple computer product timeline analogy to prompt the guests on future product form factors like chewable coffee cubes. | |
| Quantified Self, Sensor Data, and Personalized Nootropics | 4 | 4 | 0 | 1 | Saku observes that individual variance makes generic supplements unreliable, framing the value of quantified self tracking, which Jeff expands on using genomic and biome data concepts. | |
| Experiential Effects: Calm Focus vs. Overstimulation | 4 | 4 | 0 | 1 | Kyle actively reframes the discussion to contrast overstimulation with sustained focus, while Michael references the Yerkes-Dodson psychological curve. | |
| Democratization, Network Effects, and Societal Impact | 7 | 3 | 1 | 5 | Kyle pushes back on potential social divides caused by cognitive tools, and demonstrates technical expertise by explaining Metcalfe's Law via Ethernet history. |